Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 4—April 2025
Research

Neutralizing Antibodies against California Serogroup Orthobunyaviruses in Human Serum Samples, Montana, USA

Tyson A. Woods1, Stephen F. Johnson1, Alyssa B. Evans2, and Karin E. PetersonComments to Author 
Author affiliation: Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA

Main Article

Table 1

Positivity of samples tested in a study of neutralizing antibodies against California serogroup orthobunyaviruses in human serum samples, Montana, USA*

Characteristics Total Total – SW2 % JCV-positive,
n = 159
% Dual positive samples, n = 87
Hospital region
NW SW1 SW2 NC SC E
Total samples
190
103
212
201
100
100
906
694
NA
NA
JCV-positive
55 (29)
21 (20)
31 (15)
35 (17)
17 (17)
31 (31)
190 (21)
159 (23)
100
NA
Cross-reactivity
Single high titer
JCV 18 6 ND 7 4 3 NA 38 (5.4) 23.8 NA
SSHV ND ND ND ND ND ND NA 0 0 NA
LACV ND ND ND ND ND 10 NA 10 (1) 6.2 NA
CEV 4 1 ND 5 4 4 NA 18 (3) 11.3 NA
TVTV 1 2 ND 1 2 NA 6 (1) 3.8 NA
CVV ND ND ND ND ND ND NA 0 0 NA
Dual or triple high titers†
Total no. 32 12 ND 22 9 12 NA 87 (12) 54.7 100
JCV + SSHV ND ND ND ND ND ND NA 0 0 0
JCV + LACV 1 ND ND 1 ND 1 NA 3 (0.4) 1.9 3.4
JCV + CEV 13 2 ND 8 6 4 NA 33 (4.8) 20.7 37.9
JCV + TVTV 7 ND ND 7 ND ND NA 14 (2) 8.8 16.1
SSHV + LACV ND ND ND ND ND ND NA 0 0 0
SSHV + CEV 1 ND ND 1 1 ND NA 3 (0.4) 1.9 1
LACV + CEV 1 ND ND ND 1 ND NA 2 (0.2) 1.2 2.3
LACV + TVTV ND ND ND ND ND 2 NA 2 (0.2) 1.2 2.3
CEV + TVTV ND ND ND ND ND ND NA 0 0 0
Triple 9 10 ND 5 1 5 NA 30 (4.3) 18.9 34.5

*Values are no. (%) except as indicated. CEV, California encephalitis virus; E, East; JCV, James Canyon virus; LACV, La Crosse virus; NA, not applicable; NC, north central; ND, not detected; NW, northwest; SC, south central; SSHV, snowshoe hare virus; SW, south-west; TVTV, Trivittatus virus.

Main Article

1These first authors contributed equally to this article.

2Current affiliation: Department of Microbiology and Cell Biology, Montana State University, Bozeman, Montana, USA

Page created: February 08, 2025
Page updated: March 10, 2025
Page reviewed: March 10, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external